Region Skane, Kvinnokliniken, University Hopsital MAS
Malmö, SE 20502, Sweden
NCT Number: NCT01033903
The main objective of the study is to determine if there is a difference in the number of women with a complete miscarriage after 10 days between expectant management versus treatment with 800 micrograms of misoprostol intravaginally in women with an an incomplete miscarriage before 14 weeks and a gestational sac retained in the uterus.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Malmö, SE 20502, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
800 micrograms intravaginally ONCE
Time frame: 10 days
Time frame: 17 days, 24 days, 31 days
Region Skane
Other
Which is the Optimal Treatment for Miscarriage With a Gestational ac in the Uterus and Which Factors Can Predict if the Treatment Will be Successful?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07646275
Abortion, Spontaneous, Early Pregnancy Loss
Sanliurfa, Şanliurfa, Turkey (Türkiye)
View Trial DetailsNCT05449171
Abortion, Spontaneous, Female Urogenital Diseases and Pregnancy Complications
Naples, Italy
View Trial DetailsNCT03636451
Abortion Early, Abortion in First Trimester
La Jolla, California, United States
View Trial DetailsNCT03703401
Abortion, Habitual, Abortion, Spontaneous
Birmingham, West Midands, United Kingdom
View Trial Details